興業合金(00505.HK)上半年淨利1.62億元 同比增長278.85%
格隆匯8月31日丨興業合金(00505.HK)發佈公吿,截至2021年6月30日止6個月,實現收益31.68億元(人民幣,下同),同比增長62.37%;公司擁有人應占溢利1.62億元,同比增長278.85%;基本每股盈利19.94分。
2021年上半年,集團銅板帶總產量達到77,171噸,總銷量達到76,696噸。另外,集團的銅板帶業務實現銷售收入人民幣31.61億元,比2020年同期上升62.7%。再者,銅業務實現淨利潤人民幣1.628億元,與去年同期淨利潤(不包括應收及應付或然代價公平值變動)人民幣39.3百萬元相比增加314.2%,主要是由於銅價上升和銷量增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.